Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COG7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF226 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NSMCE4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RX5-TAX1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PPFIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHLHE22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMWD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMND5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPCDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PABPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on